Clinical Trial Update: Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients [Phase 3]

View source ↗

Summary

A Phase 3 head-to-head trial comparing inhaled tiotropium + olodaterol fixed-dose combination to fluticasone propionate + salmeterol fixed-dose combination in c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone propionate/salmeterol (fluticasone propionate/salmeterol)
• Stiolto Respimat (tiotropium + olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2016-02-12